Outcome and Cost-Effectiveness Analysis of Long-acting G-CSF as Primary Prophylaxis of Neutropenia Induced by Chemotherapy in Breast Cancer Patients, From a Retrospective Study

PURPOSE: This retrospective analysis aimed to evaluate the clinical outcomes and cost-effectiveness of long-acting granulocyte-colony stimulating factor as primary prophylaxis of neutropenia caused by chemotherapy for breast cancer. METHODS: Patients with breast cancer who received long- or short-ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yaqin, Zhao, Chenglong, Ma, Peizhi, Jiang, Dandan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827532/
https://www.ncbi.nlm.nih.gov/pubmed/36598048
http://dx.doi.org/10.1177/10732748221140289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827532/
https://www.ncbi.nlm.nih.gov/pubmed/36598048
http://dx.doi.org/10.1177/10732748221140289

Ejemplares similares